Bloomage BioTechnology H1 2026 revenue, profit fall; gross margin holds
H1 2026 revenue fell 22% and net profit fell 31%, while gross margin stayed strong at 68%.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.